tiprankstipranks
Moderna (MRNA)
NASDAQ:MRNA
Holding MRNA?
Track your performance easily

Moderna (MRNA) Technical Analysis

16,249 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Moderna’s (MRNA) Moving Averages Convergence Divergence (MACD) indicator is -5.77, suggesting Moderna is a Buy.
Moderna’s (MRNA) 20-Day exponential moving average is 46.07, while Moderna’s (MRNA) share price is $38.25, making it a Sell.
Moderna’s (MRNA) 50-Day exponential moving average is 57.04, while Moderna’s (MRNA) share price is $38.25, making it a Sell.

Moderna (MRNA) Pivot Points

Nov 22, 2024, 03:14 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
34.17
35.59
36.44
37.86
38.71
40.13
40.98
Fibonacci
35.59
36.46
36.99
37.86
38.73
39.26
40.13
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Moderna (MRNA) Moving Averages

Nov 22, 2024, 03:14 PM
Period
Simple
Exponential
MA5
38.07Sell
38.63Sell
MA10
41.58Sell
41.52Sell
MA20
47.70Sell
46.07Sell
MA50
56.13Sell
57.04Sell
MA100
76.96Sell
71.84Sell
MA200
96.68Sell
86.03Sell
Moderna’s (MRNA) 10-Day exponential moving average is 41.52, while Moderna’s (MRNA) share price is $38.25, making it a Sell.
Moderna’s (MRNA) 100-Day exponential moving average is 71.84, while Moderna’s (MRNA) share price is $38.25, making it a Sell.
Moderna’s (MRNA) stock price is $38.25 and Moderna’s (MRNA) 50-day simple moving average is 56.13, creating a Sell signal.
Moderna’s (MRNA) stock price is $38.25 and Moderna’s (MRNA) 100-day simple moving average is 76.96, creating a Sell signal.
Moderna’s (MRNA) stock price is $38.25 and Moderna’s (MRNA) 200-day simple moving average is 96.68, creating a Sell signal.

Moderna (MRNA) Technical Indicators

Nov 22, 2024, 03:14 PM
Name
Value
Implied Action
RSI (14)
20.53
Buy
STOCH (9,6)
10.81
Buy
STOCHRSI (14)
10.11
Buy
MACD (12,26)
-5.77
Buy
ADX (14)
38.29
Neutral
Williams %R
-94.54
Buy
CCI (14)
-113.62
Buy
ATR (14)
2.83
-
Ultimate Oscillator
36.97
Neutral
ROC
-32.05
Sell
Moderna’s (MRNA) Relative Strength Index (RSI) is 20.53, creating a Buy signal.
Moderna’s (MRNA) Trend Strength Indicator (ADX) is 38.29, creating a Neutral signal.
Moderna’s (MRNA) Commodity Channel Index (CCI) is -113.62, creating a Buy signal.
Moderna’s (MRNA) Price Rate of Change (ROC) is -32.05, creating a Sell signal.

FAQ

Is MRNA a Buy, Hold, or Sell?
Based on MRNA’s technical indicators, MRNA is a Sell.
    What is MRNA’s RSI (14)?
    MRNA’s RSI (14) is 20.53, which suggests MRNA is a Buy.
      What is MRNA’s MACD?
      MRNA’s MACD is -5.77, which suggests MRNA is a Buy.
        What is MRNA’s 5-day moving average?
        MRNA’s 5-day moving average is 38.07, which suggests MRNA is a Sell.
          What is MRNA’s 20-day moving average?
          MRNA 20-day moving average is 47.70, which suggests MRNA is a Sell.
            What is MRNA’s 50-day moving average?
            MRNA’s 50-day moving average is 56.13, which suggests MRNA is a Sell.
              What is MRNA’s 200-day moving average?
              MRNA’s 200-day moving average is 96.68, which suggests MRNA is a Sell.
                What is MRNA’s Williams % R (14)?
                MRNA’s Williams % R (14) is -94.54, which suggests MRNA is a Buy.
                  What is MRNA’s CCI (14)?
                  MRNA’s CCI (14) is -113.62, which suggests MRNA is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis